Monte Rosa Therapeutics (GLUE): Best Growth Stocks Under $20 to Buy

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) is one of the best growth stocks under $20 to buy. On May 7, Monte Rosa reported progress across its clinical-stage pipeline, with three programs advancing toward Phase 2 studies. MRT-8102, an NEK7-directed molecular glue degrader/MGD for inflammatory diseases, showed significant CRP reductions in early trials. The company plans to initiate multiple Phase 2 studies for MRT-8102 starting in H2 2026, targeting cardiovascular risk, gout, and hidradenitis suppurativa.

The company’s VAV1-directed MGD, MRT-6160, is progressing toward Phase 2 studies for immune-mediated diseases in collaboration with Novartis. Additionally, the GSPT1-directed MRT-2359 demonstrated encouraging efficacy in metastatic castration-resistant prostate cancer/mCRPC patients with androgen receptor/AR mutations, with a new Phase 2 study in combination with apalutamide planned for Q3 2026.

Monte Rosa Therapeutics (GLUE): Best Growth Stocks Under $20 to Buy

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) remains in a solid financial position, reporting $671 million in cash and equivalents, which is expected to support operations into 2029. Beyond its clinical assets, the company is advancing preclinical programs, including a cyclin E1-directed MGD for solid tumors, with an IND application expected in H2 2026.

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) is a Massachusetts-based clinical-stage biotechnology company developing novel small-molecule precision medicines. Incepted in 2019, the company maintains a strategic partnership and licensing agreement with F. Hoffmann-La Roche Ltd.

While we acknowledge the risk and potential of GLUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GLUE and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1